Mengyao Wu

1.6k total citations
70 papers, 1.1k citations indexed

About

Mengyao Wu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Mengyao Wu has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 22 papers in Oncology and 21 papers in Cancer Research. Recurrent topics in Mengyao Wu's work include Inflammatory Biomarkers in Disease Prognosis (10 papers), MicroRNA in disease regulation (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Mengyao Wu is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (10 papers), MicroRNA in disease regulation (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Mengyao Wu collaborates with scholars based in China, United States and Taiwan. Mengyao Wu's co-authors include Fei‐Ran Gong, Mengdan Xu, Meng Shen, Min Tao, Weiming Duan, Kai Chen, Qiaoming Zhi, Min Tao, Liu‐Mei Shou and Min Tao and has published in prestigious journals such as Journal of Biological Chemistry, ACS Nano and Oncogene.

In The Last Decade

Mengyao Wu

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengyao Wu China 20 519 365 262 211 149 70 1.1k
Armel Hervé Nwabo Kamdje Cameroon 19 685 1.3× 349 1.0× 268 1.0× 160 0.8× 120 0.8× 46 1.4k
Shiquan Liu China 21 742 1.4× 244 0.7× 262 1.0× 146 0.7× 189 1.3× 74 1.4k
Lan Wang China 25 905 1.7× 274 0.8× 338 1.3× 367 1.7× 231 1.6× 74 1.8k
Chao‐Wen Cheng Taiwan 22 578 1.1× 249 0.7× 191 0.7× 396 1.9× 143 1.0× 65 1.4k
Dan Chen China 18 873 1.7× 241 0.7× 332 1.3× 229 1.1× 193 1.3× 77 1.5k
Yingsong Wu China 19 667 1.3× 175 0.5× 285 1.1× 219 1.0× 98 0.7× 55 1.2k
Yanling Zhao China 22 1.0k 2.0× 385 1.1× 348 1.3× 240 1.1× 176 1.2× 48 1.5k
Yan Cui China 19 900 1.7× 342 0.9× 182 0.7× 218 1.0× 84 0.6× 48 1.6k
Atieh Pourbagheri‐Sigaroodi Iran 22 638 1.2× 277 0.8× 214 0.8× 285 1.4× 97 0.7× 59 1.4k

Countries citing papers authored by Mengyao Wu

Since Specialization
Citations

This map shows the geographic impact of Mengyao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengyao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengyao Wu more than expected).

Fields of papers citing papers by Mengyao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengyao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengyao Wu. The network helps show where Mengyao Wu may publish in the future.

Co-authorship network of co-authors of Mengyao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengyao Wu. A scholar is included among the top collaborators of Mengyao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengyao Wu. Mengyao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Lingling, Tiantian Xu, Guoying Wang, et al.. (2025). Applications and prospects of phosphoproteomics in renal disease research. PeerJ. 13. e18950–e18950.
2.
3.
Wang, Ling‐Yang, et al.. (2024). Metforminium 5-fluorouracilate: The first codrug molecular salt of 5-fluorouracil demonstrating perfected in vitro/vivo characteristics and synergic antitumor effects. Journal of Molecular Structure. 1308. 138084–138084. 2 indexed citations
4.
Xu, Keyang, Jianxian Ge, Xuyi Luo, et al.. (2024). Targeting Ferroptosis in Parkinson’s Disease: Mechanisms and Emerging Therapeutic Strategies. International Journal of Molecular Sciences. 25(23). 13042–13042. 15 indexed citations
5.
Wang, Wei, et al.. (2024). Pharmacokinetic and tissue distribution analysis of bioactive compounds from Fuke Qianjin capsules in rats by a validated UPLC MS/MS method. Journal of Pharmaceutical and Biomedical Analysis. 243. 116069–116069. 1 indexed citations
6.
An, Lili, Wen‐Hao Guo, Mengyao Wu, et al.. (2024). Genome editing of FTR42 improves zebrafish survival against virus infection by enhancing IFN immunity. iScience. 27(4). 109497–109497. 7 indexed citations
7.
Wu, Mengyao, et al.. (2024). Spatial proteomics: unveiling the multidimensional landscape of protein localization in human diseases. Proteome Science. 22(1). 7–7. 10 indexed citations
8.
9.
10.
Zhang, Lele, Feiya Sheng, Yong Yang, et al.. (2022). Integrative transcriptomics and proteomics analyses to reveal the therapeutic effect and mechanism of Buxue Yimu Pills in medical-induced incomplete abortion rats. Journal of Ethnopharmacology. 305. 116113–116113. 5 indexed citations
11.
Li, Yiying, Fei He, Qiwang Lin, et al.. (2021). ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers. Oncogene. 40(32). 5131–5141. 26 indexed citations
12.
Liu, Senquan, Mengyao Wu, Jiusheng Deng, et al.. (2021). BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells. Molecular Therapy. 29(5). 1918–1932. 17 indexed citations
13.
Lu, Yujie, Wen‐Jie Wang, Min Jiang, et al.. (2019). Prognostic values of platelet-associated indicators in advanced breast cancer. Translational Cancer Research. 8(4). 1326–1335. 1 indexed citations
14.
Wu, Jing, Fei‐Ran Gong, Mengyao Wu, et al.. (2019). Prognostic evaluation of resectable colorectal cancer using platelet‑associated indicators. Oncology Letters. 18(1). 571–580. 27 indexed citations
15.
Yu, Jie, Yan Zhang, Shengfei Wang, et al.. (2019). Inflammation Promotes Progression of Pancreatic Cancer Through WNT/β-Catenin Pathway-Dependent Manner. Pancreas. 48(8). 1003–1014. 14 indexed citations
16.
Wang, Yi, Mengdan Xu, Fei‐Ran Gong, et al.. (2018). The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers. BMC Gastroenterology. 18(1). 99–99. 10 indexed citations
17.
You, Yuehua, Yuelin Li, Ming‐Qing Li, et al.. (2017). Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells. Clinical & Experimental Immunology. 191(1). 60–73. 65 indexed citations
18.
Lian, Lian, Youyou Xia, Chong Zhou, et al.. (2015). Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer. Cancer Biomarkers. 15(6). 899–907. 80 indexed citations
19.
Wang, Wenjie, Mengyao Wu, Meng Shen, et al.. (2015). Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib. International Journal of Oncology. 47(5). 1912–1922. 35 indexed citations
20.
Wu, Mengyao, et al.. (2003). Absolute in vivo quantitation of myocardial activity. 1999 IEEE Nuclear Science Symposium. Conference Record. 1999 Nuclear Science Symposium and Medical Imaging Conference (Cat. No.99CH37019). 3. 1282–1286.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Armel Hervé Nwabo Kamdje Breakdown of academic impact, for papers by Shiquan Liu Breakdown of academic impact, for papers by Lan Wang Breakdown of academic impact, for papers by Chao‐Wen Cheng Breakdown of academic impact, for papers by Dan Chen Breakdown of academic impact, for papers by Yingsong Wu Breakdown of academic impact, for papers by Yanling Zhao Breakdown of academic impact, for papers by Yan Cui Breakdown of academic impact, for papers by Atieh Pourbagheri‐Sigaroodi
Rankless by CCL
2026